| |
|
|
|
CASI Pharmaceuticals Inc.  
|
|
3.305 -0.005 (-0%) |
11-20 16:00 |
|
Open: |
3.31 |
Pre close: |
3.31 |
Target:
|
4.04
|
|
High: |
3.48 |
Low: |
3.28 |
Resistance:
|
3.46
3.67
|
|
Volume: |
157,931 |
Market Cap: |
318M |
Support:
|
3.11
2.59
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.28
 |
MACD |
MACD(12,26):
|
-0.01 |
|
MA(20): |
3.27  |
Signal(12,26,9): |
-0.01 |
|
MA(100): |
3.23 |
Stochastic Oscillator |
%K(14,3):
|
56.40 |
|
MA(250): |
3.37 |
%D(3): |
48.40 |
|
Average Volume(K) |
3-Month: |
15378
|
52-Week |
High:
|
5.20 |
|
10-Days: |
7489 |
Low: |
2.83 |
|
RSI |
RSI(14):
|
52.78 |
Change(%): |
-12.8 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.444 |
Return on Equity (ttm) |
-39.5 |
Shares Out. (M) |
96.35 |
|
EPS Est. Current Year |
-0.150 |
Return on Assets (ttm) |
-20.7 |
Shares Float (M) |
35.73 |
|
EPS Est. Next Year |
-0.190 |
PEG Ratio |
0.00 |
% Held by Insiders |
41.36 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
21.00 |
|
Forward EPS |
-0.190 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
3910 |
|
Book Value (p.s.) |
0.830 |
EBITDA (p.s.) |
-0.371 |
P/E |
-7.44 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
3.98 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-33.57 |
P/S |
110.16 |
|
Operating Margin |
-1361.66 |
Levered Free Cash Flow
(M) |
-29.96 |
P/CF |
-9.49 |
|
|
|
|
|
|
